The Cooper Companies stock (US2166481027): Drops 0.80% to $59.47
The Cooper Companies stock (COO) dropped 0.80% to $59.47 on May 13, 2026, marking a 27.4% year-to-date decline. Despite the recent dip, the company, specializing in vision care and surgical devices, maintains strong fundamentals and net margins, outperforming some competitors in the healthcare sector. Investors are watching its performance in the growing US healthcare market.
How this was made

The 30-second read
Why it matters
The 0.80% drop may reflect short-term profit-taking or sector adjustments, with no immediate fundamental concerns.
Market read
The news is relevant primarily to investors in healthcare, especially those with exposure to COO.
What to watch
Potential upcoming earnings reports or sector-wide regulatory changes could influence stock performance.
Background
The Cooper Companies operates in vision care and surgical devices, with recent stock decline amid broader healthcare sector fluctuations.
Ticker impact
The news pertains directly to Cooper Companies (COO), highlighting a recent stock decline.
Likely minimal impact on long-term valuation; short-term volatility may persist.
The stock's recent decline is modest and within typical market fluctuations, with no immediate fundamental concerns.
Market effects
The healthcare sector may experience slight volatility; specific to vision care and surgical devices.
Limited regional impact, primarily US-focused.
Minimal global market implications.
Counterpoint
The decline could signal upcoming challenges in the healthcare sector or company-specific issues, warranting caution.
Key entities
- CompanyThe Cooper Companies
A healthcare company specializing in vision care and surgical devices.
- News SourceAD HOC NEWS
Provider of financial news and market updates.



